Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ?

NCT ID: NCT02861053

Last Updated: 2026-01-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

3 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-11

Study Completion Date

2020-03-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The chronic fatigue is observed in approximately 40 % of the patients with a chronic quiet inflammatory bowel disease (IBD) and impacts the quality of life of the patients. The beneficial role of a regular physical activity on the quality of life of patients having an IBD was demonstrated in 5 studies including only 1 controlled one \[Bilski, on 2013\]. The mechanism by which the physical activity could improve the quality of life of the patients remains unknown (stress decreased, reduction of the inflammatory process) \[Bilski, on 2014\]. Several studies concerning other chronic pathologies such as fibromyalgia, have demonstrated the beneficial effect of a regular physical exercise to reduce the fatigue of patients. It was recently demonstrated that the chronic fatigue observed in patients with IBD came along with a physical reduction in the performances during the exercise test and a reduction in the physical activity of the patients \[Vogelaar, 2015\].

Our hypothesis is that a regular moderate physical activity could improve physical performance during an effort et could reduce the chronic fatigue and improve their quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Bowel Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

chronic quiet inflammatory bowel disease patient (IBD)

Patient with chronic quiet inflammatory bowel disease patient (IBD) with regular and moderate physical activity

Group Type EXPERIMENTAL

regular and moderate physical activity

Intervention Type OTHER

regular and moderate physical activity will be done 3 times per week more than usual

No regular and moderate physical activity more than usual

Intervention Type OTHER

regular and moderate physical activity will be done as usual

chronic quiet inflammatory bowel disease Patient (IBD)

Patient with chronic quiet inflammatory bowel disease patient (IBD) with no regular and moderate physical activity more than usual

Group Type SHAM_COMPARATOR

regular and moderate physical activity

Intervention Type OTHER

regular and moderate physical activity will be done 3 times per week more than usual

No regular and moderate physical activity more than usual

Intervention Type OTHER

regular and moderate physical activity will be done as usual

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

regular and moderate physical activity

regular and moderate physical activity will be done 3 times per week more than usual

Intervention Type OTHER

No regular and moderate physical activity more than usual

regular and moderate physical activity will be done as usual

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients ≥ 18 years old
* Patients suffering from IBD
* Patients with a FACIT score \< 30
* Patients with BD in remission with a C-reactiv protein dose \< 5
* Patients with Hemoglobin dosage \> 10g/dl
* Patients with 18\<BMI\<30 kg/m2
* Informed consent given by the patients
* Patients affiliated to the social security
* Patients living not far from the centre where the rehabilitation program will be performed
* Women with no risk of pregnancy (menopausal women or with contraceptive drugs).

Exclusion Criteria

* Patients ≥ 45 years old
* Inability to walk or to ride a bike
* Contraindication to practice physical exercise
* Contraindication to exercise test
* Participation to another research study within the week preceding the beginning of the protocol
* Patients unstable smokers
* Patients unable to keep their medical treatment stable along the study
* Patients with a regular intensive physical practice
* Patients with depression (HAD\>11/21)
* Patients with bad sleep quality (PSQI score \>5)
* Pregnant or breast-feeding patients
* Patients under legal protection
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Rouen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David DEBEAUMONT, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Rouen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rouen University Hospital

Rouen, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016/013/HP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.